[1]
Ramachandran R, Kaundal U, Girimaji N, Rakha A, Rathi M, Gupta KL, Kohli HS, Jha V. Regulatory B Cells Are Reduced and Correlate With Disease Activity in Primary Membranous Nephropathy. Kidney international reports. 2020 Jun:5(6):872-878. doi: 10.1016/j.ekir.2020.03.023. Epub 2020 Mar 30
[PubMed PMID: 32518869]
[2]
Ronco P, Debiec H. Molecular Pathogenesis of Membranous Nephropathy. Annual review of pathology. 2020 Jan 24:15():287-313. doi: 10.1146/annurev-pathol-020117-043811. Epub 2019 Oct 17
[PubMed PMID: 31622560]
[3]
Sethi S, Debiec H, Madden B, Charlesworth MC, Morelle J, Gross L, Ravindran A, Buob D, Jadoul M, Fervenza FC, Ronco P. Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy. Kidney international. 2020 Jan:97(1):163-174. doi: 10.1016/j.kint.2019.09.014. Epub 2019 Oct 7
[PubMed PMID: 31901340]
[4]
Couser WG. Primary Membranous Nephropathy. Clinical journal of the American Society of Nephrology : CJASN. 2017 Jun 7:12(6):983-997. doi: 10.2215/CJN.11761116. Epub 2017 May 26
[PubMed PMID: 28550082]
[5]
Fervenza FC, Sethi S, Specks U. Idiopathic membranous nephropathy: diagnosis and treatment. Clinical journal of the American Society of Nephrology : CJASN. 2008 May:3(3):905-19. doi: 10.2215/CJN.04321007. Epub 2008 Jan 30
[PubMed PMID: 18235148]
[6]
Keri KC, Blumenthal S, Kulkarni V, Beck L, Chongkrairatanakul T. Primary membranous nephropathy: comprehensive review and historical perspective. Postgraduate medical journal. 2019 Jan:95(1119):23-31. doi: 10.1136/postgradmedj-2018-135729. Epub 2019 Jan 25
[PubMed PMID: 30683678]
Level 3 (low-level) evidence
[7]
Menon S, Valentini RP. Membranous nephropathy in children: clinical presentation and therapeutic approach. Pediatric nephrology (Berlin, Germany). 2010 Aug:25(8):1419-28. doi: 10.1007/s00467-009-1324-5. Epub 2009 Nov 12
[PubMed PMID: 19908069]
[8]
Cybulsky AV. Membranous nephropathy. Contributions to nephrology. 2011:169():107-125. doi: 10.1159/000313948. Epub 2011 Jan 20
[PubMed PMID: 21252514]
[9]
Akankwasa G, Jianhua L, Guixue C, Changjuan A, Xiaosong Q. Urine markers of podocyte dysfunction: a review of podocalyxin and nephrin in selected glomerular diseases. Biomarkers in medicine. 2018 Aug:12(8):927-935. doi: 10.2217/bmm-2018-0152. Epub 2018 Jul 6
[PubMed PMID: 29976076]
[10]
Alawieh R, Brodsky SV, Satoskar AA, Nadasdy T, Parikh SV, Rovin B, Cassol CA. Membranous Nephropathy With Crescents. Kidney international reports. 2020 Apr:5(4):537-541. doi: 10.1016/j.ekir.2020.01.010. Epub 2020 Jan 30
[PubMed PMID: 32274459]
[11]
Zhang XD, Cui Z, Zhang MF, Wang J, Zhang YM, Qu Z, Wang X, Huang J, Wang F, Meng LQ, Cheng XY, Wang SX, Liu G, Zhao MH. Clinical implications of pathological features of primary membranous nephropathy. BMC nephrology. 2018 Aug 28:19(1):215. doi: 10.1186/s12882-018-1011-5. Epub 2018 Aug 28
[PubMed PMID: 30153817]
[12]
Sato S, Kitamura H, Ghazizadeh M, Adachi A, Sasaki Y, Ishizaki M, Inoue K, Wakamatsu K, Sugisaki Y. Occurrence of hyaline droplets in renal biopsy specimens: an ultrastructural study. Medical molecular morphology. 2005 Mar:38(1):63-71
[PubMed PMID: 16158182]
[14]
Zhang LJ, Zhang Z, Li SJ, Meinel FG, Nance JW Jr, Zhou CS, Zhao YE, Schoepf UJ, Lu GM. Pulmonary embolism and renal vein thrombosis in patients with nephrotic syndrome: prospective evaluation of prevalence and risk factors with CT. Radiology. 2014 Dec:273(3):897-906. doi: 10.1148/radiol.14140121. Epub 2014 Jul 28
[PubMed PMID: 25072187]
[15]
Bande U, Moger V, Kamath V, Mallikarjunaswamy, Chandrashekar. Acute kidney injury in a patient with membranous nephropathy - a case report. Journal of clinical and diagnostic research : JCDR. 2013 Oct:7(10):2290-1. doi: 10.7860/JCDR/2013/6610.3500. Epub 2013 Oct 5
[PubMed PMID: 24298505]
Level 3 (low-level) evidence
[16]
Zhang J, Pan M, Zhang J, You X, Li D, Lin F, Lu G. Serum uric acid is an independent predictor of renal outcomes in patients with idiopathic membranous nephropathy. International urology and nephrology. 2019 Oct:51(10):1797-1804. doi: 10.1007/s11255-019-02254-7. Epub 2019 Aug 28
[PubMed PMID: 31463703]
[17]
Hou J, Cheng Y, Hou Y, Wu H. Lower Serum and Higher Urine Immunoglobulin G Are Associated with an Increased Severity of Idiopathic Membranous Nephropathy. Annals of clinical and laboratory science. 2019 Nov:49(6):777-784
[PubMed PMID: 31882429]
[18]
Mirkovic K, Frenay AS, van den Born J, van Goor H, Navis G, de Borst MH, NIGRAM consortium. Sodium restriction potentiates the renoprotective effects of combined vitamin D receptor activation and angiotensin-converting enzyme inhibition in established proteinuric nephropathy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2017 Aug 1:32(8):1293-1301. doi: 10.1093/ndt/gfv304. Epub
[PubMed PMID: 26311058]
[19]
Bomback AS, Fervenza FC. Membranous Nephropathy: Approaches to Treatment. American journal of nephrology. 2018:47 Suppl 1():30-42. doi: 10.1159/000481635. Epub 2018 May 31
[PubMed PMID: 29852477]
[20]
Cattran D, Brenchley P. Membranous nephropathy: thinking through the therapeutic options. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2017 Jan 1:32(suppl_1):i22-i29. doi: 10.1093/ndt/gfw404. Epub
[PubMed PMID: 28391348]
[21]
Bomback AS, Derebail VK, McGregor JG, Kshirsagar AV, Falk RJ, Nachman PH. Rituximab therapy for membranous nephropathy: a systematic review. Clinical journal of the American Society of Nephrology : CJASN. 2009 Apr:4(4):734-44. doi: 10.2215/CJN.05231008. Epub 2009 Mar 11
[PubMed PMID: 19279120]
Level 1 (high-level) evidence
[22]
Goździk M, Płuciennik A, Zawiasa-Bryszewska A, Nowicka M, Nowicka Z, Wągrowska-Danilewicz M, Kurnatowska I. Acute Kidney Injury Following Exposure to Calcineurin Inhibitors in a Patient with Idiopathic Membranous Nephropathy. Drug safety - case reports. 2019 Oct 5:6(1):9. doi: 10.1007/s40800-019-0103-x. Epub 2019 Oct 5
[PubMed PMID: 31587119]
Level 3 (low-level) evidence
[23]
Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC, Toronto Glomerulonephritis Registry Group. Idiopathic membranous nephropathy: definition and relevance of a partial remission. Kidney international. 2004 Sep:66(3):1199-205
[PubMed PMID: 15327418]
[24]
Lu W, Gong S, Li J, Wang Y. Clinicopathological features and prognosis in patients with idiopathic membranous nephropathy with hypertension. Experimental and therapeutic medicine. 2020 Apr:19(4):2615-2621. doi: 10.3892/etm.2020.8506. Epub 2020 Feb 10
[PubMed PMID: 32256741]
[25]
Lim WH, Shingde M, Wong G. Recurrent and de novo Glomerulonephritis After Kidney Transplantation. Frontiers in immunology. 2019:10():1944. doi: 10.3389/fimmu.2019.01944. Epub 2019 Aug 14
[PubMed PMID: 31475005]